News

TOKYO, JAPAN- Six months after its CEO resigned amid allegations he purchased illegal drugs, med-tech company Olympus ...
The healthcare overweighting was driven mainly by medical device-makers, with Globus Medical and Baxter added in the past year. Biotechs (Regeneron and Amgen) also played a key role here.
The healthcare overweighting was driven mainly by medical device-makers, with Globus Medical and Baxter added in the past year. Biotechs (Regeneron and Amgen) also played a key role here.